These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12120692)

  • 1. T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis.
    Griffin CM; Dehmeshki J; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH
    Mult Scler; 2002 May; 8(3):211-6. PubMed ID: 12120692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
    Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
    Griffin CM; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH
    J Neurol; 2002 Feb; 249(2):193-9. PubMed ID: 11985386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffusion tensor imaging of the normal-appearing brain tissue in relapsing-remitting multiple sclerosis].
    Yu CS; Li KC; Lin FC; Jiang TZ; Sun H; Chen B
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1260-4. PubMed ID: 16796886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
    Zivadinov R; Dwyer MG; Markovic-Plese S; Kennedy C; Bergsland N; Ramasamy DP; Durfee J; Hojnacki D; Hayward B; Dangond F; Weinstock-Guttman B
    PLoS One; 2014; 9(3):e91098. PubMed ID: 24625687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
    Lund H; Krakauer M; Skimminge A; Sellebjerg F; Garde E; Siebner HR; Paulson OB; Hesse D; Hanson LG
    PLoS One; 2013; 8(2):e56375. PubMed ID: 23441184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
    Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
    Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM
    Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging.
    Rashid W; Hadjiprocopis A; Davies G; Griffin C; Chard D; Tiberio M; Altmann D; Wheeler-Kingshott C; Tozer D; Thompson A; Miller DH
    J Neurol; 2008 Mar; 255(3):390-7. PubMed ID: 18350361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; De Masi R; Nasuelli D; Bragadin LM; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    Neuroradiology; 2001 Apr; 43(4):272-8. PubMed ID: 11338408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
    J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance fingerprinting in multiple sclerosis.
    Ontaneda D; Gulani V; Deshmane A; Shah A; Guruprakash DK; Jiang Y; Ma D; Fisher E; Rudick RA; Raza P; Kilbane M; Cohen JA; Sakaie K; Lowe MJ; Griswold MA; Nakamura K
    Mult Scler Relat Disord; 2023 Nov; 79():105024. PubMed ID: 37783196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction.
    Rashid W; Hadjiprocopis A; Griffin CM; Chard DT; Davies GR; Barker GJ; Tofts PS; Thompson AJ; Miller DH
    Mult Scler; 2004 Feb; 10(1):9-15. PubMed ID: 14760947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.
    Arnold DL; Calabresi PA; Kieseier BC; Liu S; You X; Fiore D; Hung S
    BMC Neurol; 2017 Feb; 17(1):29. PubMed ID: 28183276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study.
    Davies GR; Hadjiprocopis A; Altmann DR; Chard DT; Griffin CM; Rashid W; Parker GJ; Tofts PS; Kapoor R; Thompson AJ; Miller DH
    Mult Scler; 2007 Mar; 13(2):169-77. PubMed ID: 17439881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
    Soon D; Tozer D; Altmann D; Tofts P; Miller D
    Mult Scler; 2007 Aug; 13(7):884-94. PubMed ID: 17468443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
    Kostic D; Dincic E; Jovanovski A; Kostic S; Rancic N; Georgievski-Brkic B; Misovic M; Koprivsek K
    Acta Neurol Belg; 2023 Jun; 123(3):831-838. PubMed ID: 35397094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
    Stosic M; Ambrus J; Garg N; Weinstock-Guttman B; Ramanathan M; Kalman B; Minagar A; Munschauer FE; Galey TM; Hussein S; Bakshi R; Zivadinov R
    J Neurol; 2010 Jan; 257(1):63-71. PubMed ID: 19633967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.